Tweets by ambitioncm2020
AMBITION Electronic Data Capture Tool (EDC): Dr. David Lawrence’s YouTube Channel
AMBITION Protocol Version 2.2
ISRCTN Registry (AMBITION-cm)
The International Society for Neglected Tropical Diseases
International Society for Human and Animal Mycology
WHO: Meningitis
EDCTP and Horizon 2020
Horizon 2020 Annotated Model Grant Agreement
November 2020: Moeng et al (HIV-associated Cryptococcal Meningitis: A Review of Novel Short Course and Oral Therapies)
November 2020: Lawrence and Hirsch (Decolonising global health: transnational research partnerships under the spotlight)
October 2020: Kelentse et al (Differences in HIV-1C Viral Load and Drug Resistance Mutation between Plasma and Cerebrospinal Fluid in Patients with HIV-associated Cryptococcal Meningitis in Botswana)
September 2020: Leeme et al (Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana)
July 2020: Alufandika et al (A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration)
June 2020: Greene et al (Cryptococcal meningitis: a review of novel cryptococcal antigen screening programs in Africa. Expert Review of Anti-infective Therapy)
May 2020: Lebelonyane et al (Advanced HIV disease in the Botswana Combination Prevention Project: Prevalence, Risk Factors, and Outcomes)
May 2020: Jarvis et al (Evaluation of a Novel Semi-quantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease)
May 2020: Tenforde et al (Outcomes of reflex cryptococcal antigen (CrAg) screening in HIV-positive patients with CD4 counts of 100-200 cells/µL in Botswana)
January 2020: Tenforde et al (Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis)
April 2019: Ponatshego et al (High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study)
October 2018: Lawrence et al (AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial)
London School of Hygiene & Tropical MedicineKeppel Street, London WC1E 7HT, UK
